Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-03-06 | Jazz Pharmaceuticals plc | Carr Patricia
(SVP, Chief Accounting Officer) |
S | Ordinary Shares | D | 3704 | $116.98 - $120.85 | $438,447 |
| 2024-03-05 | Jazz Pharmaceuticals plc | GALA RENEE D
(President & COO) |
F | Ordinary Shares | D | 3622 | $117.53 - $117.53 | $425,693 |
| 2024-03-05 | Jazz Pharmaceuticals plc | Pearce Samantha
(SVP, Head of Europe & Internat) |
F | Ordinary Shares | D | 2474 | $117.53 - $117.53 | $290,769 |
| 2024-03-05 | Jazz Pharmaceuticals plc | Patil Neena M
(EVP & Chief Legal Officer) |
F | Ordinary Shares | D | 3432 | $117.53 - $117.53 | $403,362 |
| 2024-03-05 | Jazz Pharmaceuticals plc | Iannone Robert
(EVP, Global Head of R&D) |
F | Ordinary Shares | D | 4294 | $117.53 - $117.53 | $504,673 |
| 2024-03-05 | Jazz Pharmaceuticals plc | COZADD BRUCE C
(Chairman & CEO) |
F | Ordinary Shares | D | 22436 | $117.53 - $117.53 | $2,636,903 |
| 2024-03-01 | Jazz Pharmaceuticals plc | Henderson Mary El...
(SVP, Technical Operations) |
A | Ordinary Shares | A | 5178 | $0.00 - $0.00 | $0 |
| 2024-03-01 | Jazz Pharmaceuticals plc | Carr Patricia
(SVP, Chief Accounting Officer) |
A | Ordinary Shares | A | 2987 | $0.00 - $0.00 | $0 |
| 2024-03-01 | Jazz Pharmaceuticals plc | Pearce Samantha
(SVP, Head of Europe & Internat) |
A | Ordinary Shares | A | 5065 | $0.00 - $0.00 | $0 |
| 2024-03-01 | Jazz Pharmaceuticals plc | Patil Neena M
(EVP & Chief Legal Officer) |
A | Ordinary Shares | A | 12348 | $0.00 - $0.00 | $0 |
| 2024-03-01 | Jazz Pharmaceuticals plc | Iannone Robert
(EVP, Global Head of R&D) |
A | Ordinary Shares | A | 16928 | $0.00 - $0.00 | $0 |
| 2024-03-01 | Jazz Pharmaceuticals plc | GALA RENEE D
(President & COO) |
A | Ordinary Shares | A | 19916 | $0.00 - $0.00 | $0 |
| 2024-03-01 | Jazz Pharmaceuticals plc | COZADD BRUCE C
(Chairman & CEO) |
A | Ordinary Shares | A | 50187 | $0.00 - $0.00 | $0 |
| 2024-03-01 | Jazz Pharmaceuticals plc | Kennedy Patrick
(Director) |
A | Common Stock | A | 1423 | $0.00 - $0.00 | $0 |
| 2024-03-01 | Jazz Pharmaceuticals plc | Johnson Philip L
(EVP & Chief Financial Officer) |
P | Ordinary Shares | A | 12000 | $119.65 - $119.65 | $1,435,800 |
| 2024-03-01 | Jazz Pharmaceuticals plc | Johnson Philip L
(EVP & Chief Financial Officer) |
A | Ordinary Shares | A | 15932 | $0.00 - $0.00 | $0 |
| 2023-12-04 | Jazz Pharmaceuticals plc | Carr Patricia
(SVP, Chief Accounting Officer) |
S | Ordinary Shares | D | 50 | $121.39 - $121.39 | $6,069 |
| 2024-01-17 | Jazz Pharmaceuticals plc | Pearce Samantha
(SVP, Head of Europe & Internat) |
F | Ordinary Shares | D | 1038 | $119.13 - $119.13 | $123,656 |
| 2024-01-17 | Jazz Pharmaceuticals plc | Pearce Samantha
(SVP, Head of Europe & Internat) |
A | Ordinary Shares | A | 2210 | $0.00 - $0.00 | $0 |
| 2024-01-17 | Jazz Pharmaceuticals plc | Patil Neena M
(EVP & Chief Legal Officer) |
F | Ordinary Shares | D | 1656 | $119.13 - $119.13 | $197,279 |
| 2024-01-17 | Jazz Pharmaceuticals plc | Patil Neena M
(EVP & Chief Legal Officer) |
A | Ordinary Shares | A | 5087 | $0.00 - $0.00 | $0 |
| 2024-01-17 | Jazz Pharmaceuticals plc | Iannone Robert
(EVP, Global Head of R&D) |
F | Ordinary Shares | D | 1730 | $119.13 - $119.13 | $206,094 |
| 2024-01-17 | Jazz Pharmaceuticals plc | Iannone Robert
(EVP, Global Head of R&D) |
A | Ordinary Shares | A | 5970 | $0.00 - $0.00 | $0 |
| 2024-01-17 | Jazz Pharmaceuticals plc | GALA RENEE D
(President & COO) |
F | Ordinary Shares | D | 3204 | $119.13 - $119.13 | $381,692 |
| 2024-01-17 | Jazz Pharmaceuticals plc | GALA RENEE D
(President & COO) |
A | Ordinary Shares | A | 7079 | $0.00 - $0.00 | $0 |
| 2024-01-17 | Jazz Pharmaceuticals plc | COZADD BRUCE C
(Chairman & CEO) |
F | Ordinary Shares | D | 12245 | $119.13 - $119.13 | $1,458,746 |
| 2024-01-17 | Jazz Pharmaceuticals plc | COZADD BRUCE C
(Chairman & CEO) |
A | Ordinary Shares | A | 26545 | $0.00 - $0.00 | $0 |
| 2024-01-17 | Jazz Pharmaceuticals plc | Carr Patricia
(SVP, Chief Accounting Officer) |
A | Ordinary Shares | A | 1327 | $0.00 - $0.00 | $0 |
| 2023-12-04 | Jazz Pharmaceuticals plc | Smith Mark Douglas
(Director) |
S | Ordinary Shares | D | 417 | $119.27 - $119.27 | $49,735 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |